Lee Ainslie - Maverick Capital
Holding/activity history for Atara Biotherapeutics Inc (ATRA)
← All ATRA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 0.21 | $4.97–45.75 · VW $19.19i | SEC | |
| 2023 Q3 | 251,629 | 0.21 | $37.00 | $9,310,255 | SEC | ||
| 2023 Q2 | 251,629 | 0.22 | $40.25 | $10,128,048 | SEC | ||
| 2023 Q1 | 251,629 | 0.46 | Reduce 0.00% | $66.50–141.00 · VW $97.88i | $18,243,068 | SEC | |
| 2022 Q4 | 251,641 | 0.49 | Reduce 19.92% | 0.13 | $70.75–140.25 · VW $104.70i | $20,634,523 | SEC |
| 2022 Q3 | 314,233 | 0.67 | $94.50 | $29,695,000 | SEC | ||
| 2022 Q2 | 314,233 | 1.52 | $194.75 | $61,197,000 | SEC | ||
| 2022 Q1 | 314,233 | 1.33 | $232.25 | $72,981,000 | SEC | ||
| 2021 Q4 | 314,233 | 1.41 | $394.00 | $123,808,000 | SEC | ||
| 2021 Q3 | 314,233 | 1.43 | Add 1.96% | 0.03 | $295.25–458.75 · VW $373.82i | $140,619,000 | SEC |
| 2021 Q2 | 308,187 | 1.14 | Add 14.32% | 0.14 | $316.75–421.25 · VW $359.80i | $119,808,000 | SEC |
| 2021 Q1 | 269,576 | 0.88 | Reduce 7.99% | 0.18 | $336.75–546.25 · VW $431.92i | $96,778,000 | SEC |
| 2020 Q4 | 292,982 | 2.30 | Add 8.57% | 0.18 | $299.25–705.00 · VW $488.48i | $143,781,000 | SEC |
| 2020 Q3 | 269,852 | 1.63 | Reduce 0.12% | <0.01 | $283.25–408.00 · VW $335.37i | $87,432,000 | SEC |
| 2020 Q2 | 270,164 | 2.07 | Add 29.89% | 0.48 | $178.50–484.00 · VW $295.17i | $98,407,000 | SEC |
| 2020 Q1 | 207,996 | 0.93 | Add 4.87% | 0.04 | $113.00–448.50 · VW $295.70i | $44,251,000 | SEC |
| 2019 Q4 | 198,337 | 1.19 | Reduce 2.85% | 0.03 | $259.50–428.75 · VW $340.25i | $81,665,000 | SEC |
| 2019 Q3 | 204,159 | 1.06 | Add 128.62% | 0.60 | $287.50–536.25 · VW $372.13i | $72,068,000 | SEC |
| 2019 Q2 | 89,299 | 0.65 | Add 156.38% | 0.40 | $469.00–1,048.25 · VW $667.64i | $44,895,000 | SEC |
| 2019 Q1 | 34,831 | 0.47 | Buy | 0.47 | $696.25–1,049.25 · VW $916.87i | $34,613,000 | SEC |